About: Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 25 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) scientific article published on 25 March 2019 (en)
publication date	wds:Q64056352-6207B9CB-95DE-423B-A9F5-57BEDFC0FC65
publication date	2019-03-25 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64056352-669A53FC-8810-487C-91E8-4FD87A55C933
language of work or name	English
cites work	wds:Q64056352-00866744-A7EF-4CEA-8FBA-22B8698543E2 wds:Q64056352-00F83F6A-141A-4108-83C1-B17CA6B6F45B wds:Q64056352-012F9545-A870-468A-815C-9B5A559E8ACF wds:Q64056352-0A1CB197-A906-452C-A218-019987FCB676 wds:Q64056352-0AB42974-7F7D-4A3C-B279-7DDD7C66ADC8 wds:Q64056352-0B96AB38-C5C3-4BB1-ACDE-90C3DBE4B759 wds:Q64056352-1342888F-DE1A-4A65-9953-E7CD932CD038 wds:Q64056352-180386F2-5081-48F9-AD3A-A5C8083BEBE4 wds:Q64056352-235F2D1B-7D59-493F-AC92-6D479E8179D8 wds:Q64056352-31083950-F335-43DE-95BD-7B54940CE4E3 wds:Q64056352-3D17EC95-BCD7-4BD3-89D7-8FB20213D390 wds:Q64056352-4234A4CD-2DD9-46A2-B067-445D2FDA3781 wds:Q64056352-487A22B9-368F-4495-BFE2-FB7E9D012D54 wds:Q64056352-4A4088D8-72BE-40FB-9A29-44139A33519D wds:Q64056352-54D8A8E6-F28B-48A9-A351-3862A3D9522C wds:Q64056352-54F0E4C1-35B2-483F-9069-64172F4AE598 wds:Q64056352-61CFAA8B-9A54-4FD9-B3FA-C75AF8A5C817 wds:Q64056352-708F2FCA-5F5F-4B43-B4E5-2668F5196101 wds:Q64056352-74573545-260A-4B51-894B-3EA2B74E8302 wds:Q64056352-84110E8F-7341-43DC-952A-ABDE14EEDE95 wds:Q64056352-8A78677D-4CCF-4334-9E87-2B9645A54F5D wds:Q64056352-8B00151B-F0DA-464E-B1C4-EB5D49ABDB85 wds:Q64056352-8DABC604-6C06-4E55-A6E9-13FE9F12C547 wds:Q64056352-90B9A5E1-DABA-493B-907B-DC4E96459EC3 wds:Q64056352-ACE74054-FE00-455E-B596-36E2702D489C wds:Q64056352-AD3BDA5C-D9D5-4052-9715-886DC56940E9 wds:Q64056352-B64F9B06-5C31-4214-8C25-D5D99879358A wds:Q64056352-B854C3D1-EA16-4178-973F-4226B93C3159 wds:Q64056352-C8746479-E6D2-49BB-8E15-CCECCF9E359C wds:Q64056352-D6045186-1580-4E97-BCDA-FE688A585836 wds:Q64056352-DD37D146-5CAE-497B-9F95-2FF9D2B99FD6 wds:Q64056352-DFA7234B-AFFA-4C0E-A877-AE7B43FA6222 wds:Q64056352-E1FF0875-DFF1-4D33-B86D-C141A3537908 wds:Q64056352-E60EA2B8-0085-4778-A95B-A5FC91819105 wds:Q64056352-E692E922-ACCD-4736-965A-BA2153454A8D wds:Q64056352-E6FBF15A-A371-4C44-A601-E17A5AA6234B wds:Q64056352-EA62C3A9-E4E8-4753-9D80-4981198804D2 wds:Q64056352-FAADE799-FA2E-4FD6-840E-CD8421E83D96 wds:Q64056352-FBC29E6F-388D-4E72-B901-A9E05620098D
cites work	CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Pharmacology of drugs that alter multidrug resistance in cancer Taxanes: promising anti-cancer drugs. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel Doxil®--the first FDA-approved nano-drug: lessons learned Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Liposomal drug delivery: a versatile platform for challenging clinical applications. Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells. Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials Liposomal Formulations in Clinical Use: An Updated Review. Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial Sub acute toxicity assessment of glipizide engineered polymeric nanoparticles Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells. Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE). Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer. Application of validated RP-HPLC method for simultaneous determination of docetaxel and ketoconazole in solid lipid nanoparticles Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment Interactions of Self-Assembled S Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles
author name string	wds:Q64056352-298358CE-6828-4969-BFC2-63E4F5361D21 wds:Q64056352-4325FCD4-2026-4774-97F7-4F051F30EA9E wds:Q64056352-F3BF9C11-546F-41CF-B685-F0CFBD45843C
author name string	Abraham J Domb Shaheen Mahira Nagavendra Kommineni
rdfs:label	Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (en) Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (nl)
skos:prefLabel	Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (en) Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (nl)
name	Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (en) Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software